Experimental Flu Drug Outperforms Vaccines in Early Data
A new experimental flu drug, CD388, shows promise in providing up to 76% protection against influenza for an entire season, potentially outperforming traditional flu vaccines, with safety profiles similar across doses, and is moving towards phase 3 trials.